TherapeuticsMD (TXMD) Other Operating Expenses (2010 - 2026)

TherapeuticsMD (TXMD) has reported Other Operating Expenses for 17 consecutive years, with $108000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Operating Expenses rose 12.5% year-over-year to $108000.0; the trailing twelve-month figure through Jun 2026 stood at $483000.0 (changed 0.21% YoY), and the FY2025 full-year result was $560000.0, down 68.49% from the prior year.
• Other Operating Expenses rose to $108000.0 in Q2 2026 per TXMD's latest filing, from $94000.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $143.4 million in Q2 2022 and bottomed at -$18.7 million in Q1 2022.
• Historically, Other Operating Expenses has averaged $8.1 million across 5 years, with a median of $128000.0 in 2023.
• The widest YoY moves for Other Operating Expenses: up 7029.99% in 2022, down 1010.54% in 2022.
• Over 5 years, Other Operating Expenses stood at $9.6 million in 2022, then sank by 94.4% to $537000.0 in 2023, then sank by 80.07% to $107000.0 in 2024, then jumped by 42.99% to $153000.0 in 2025, then fell by 29.41% to $108000.0 in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $108000.0, $94000.0, and $153000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.